To: Jack of All Trades who wrote (1167 ) 7/23/2021 1:13:10 PM From: yard_man 1 RecommendationRecommended By Bull RidaH
Read Replies (1) | Respond to of 4394 I hate to say this -- but I have conversed with some folks who are absolutely simple when it comes to understanding the dangers of these vaccines. That Dr. Yeadon I posted link to early -- was clear before they ever started injecting folks with these about one of the real threats as the result of animal trials showed ... this mechanism provides just enough wiggle room for these war criminals to perhaps escape justice. They will say these folks have been killed by a "new deadly" strain -- when in fact they have been "pre-primed" to be killed by viruses that have been circulating for a while. I suspect this is already happening and that someone I know was already killed in this fashion (if he wasn't killed by malpractice). >> Many doctors and researchers around the world have promulgated concerns about the well-documented phenomena referred to as Antibody Dependent Enhancement (ADE) seen in some viruses such as coronaviruses. In previous SARS, MERS, Dengue fever and RSV virus vaccine trials the exposure of wild viruses to vaccine recipients resulted in severe disease, cytokine storms, and deaths in some animal and human trials. The phenomenon of ADE did not present initially in vaccine recipients, rather it presented after vaccine recipients were exposed to wild viruses. This is the reason we do not have a vaccine for the common cold, MERS and SARS which is 78% homologous with SarsCov2 (based on analysis of the digital genome). Immunology Professor Dolores Cahill warned that this disease enhancement may cause many vaccine recipients to die months or years down the road. Esteemed German infectious disease specialist, Dr Sucharit Bhakdi opined : This vaccine will lead you to your doom.” Researchers in The International Journal of Clinical Practice stated : The absence of ADE evidence in COVID-19 vaccine data so far does not absolve investigators from disclosing the risk of enhanced disease to vaccine trial participants, and it remains a realistic, non-theoretical risk to the subjects. Unfortunately, no vaccines for any of the known human CoVs have been licensed , although several potential SARS-CoV and MERS-CoV vaccines have advanced into human clinical trials for years, suggesting the development of effective vaccines against human CoVs has always been challenging.”